A detailed history of Banco Bilbao Vizcaya Argentaria, S.A. transactions in Incyte Corp stock. As of the latest transaction made, Banco Bilbao Vizcaya Argentaria, S.A. holds 7,458 shares of INCY stock, worth $565,838. This represents 0.01% of its overall portfolio holdings.

Number of Shares
7,458
Holding current value
$565,838
% of portfolio
0.01%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$57.33 - $68.61 $427,567 - $511,693
7,458 New
7,458 $492,000
Q2 2024

Aug 06, 2024

BUY
$51.18 - $63.75 $24,771 - $30,855
484 Added 5.75%
8,898 $539,000
Q1 2024

May 13, 2024

BUY
$56.55 - $66.59 $77,247 - $90,961
1,366 Added 19.38%
8,414 $479,000
Q4 2023

Feb 13, 2024

SELL
$52.16 - $64.19 $3.85 Million - $4.74 Million
-73,814 Reduced 91.28%
7,048 $442,000
Q3 2023

Nov 08, 2023

SELL
$57.77 - $65.93 $25,592 - $29,206
-443 Reduced 0.54%
80,862 $4.67 Million
Q2 2023

Aug 04, 2023

SELL
$60.95 - $75.51 $37,057 - $45,910
-608 Reduced 0.74%
81,305 $5.06 Million
Q1 2023

May 09, 2023

BUY
$70.23 - $86.01 $5.4 Million - $6.62 Million
76,944 Added 1548.48%
81,913 $5.92 Million
Q4 2022

Feb 13, 2023

SELL
$67.18 - $84.11 $29,156 - $36,503
-434 Reduced 8.03%
4,969 $399,000
Q3 2022

Nov 14, 2022

BUY
$66.18 - $82.86 $31,964 - $40,021
483 Added 9.82%
5,403 $361,000
Q2 2022

Aug 08, 2022

SELL
$66.18 - $83.18 $41,494 - $52,153
-627 Reduced 11.3%
4,920 $374,000
Q1 2022

May 12, 2022

SELL
$66.02 - $79.71 $60,804 - $73,412
-921 Reduced 14.24%
5,547 $451,000
Q4 2021

Feb 15, 2022

BUY
$63.34 - $74.11 $118,255 - $138,363
1,867 Added 40.58%
6,468 $480,000
Q3 2021

Nov 12, 2021

BUY
$68.67 - $84.02 $6,935 - $8,486
101 Added 2.24%
4,601 $316,000
Q2 2021

Aug 06, 2021

BUY
$79.87 - $87.53 $27,794 - $30,460
348 Added 8.38%
4,500 $379,000
Q1 2021

May 13, 2021

SELL
$76.02 - $100.5 $520,204 - $687,721
-6,843 Reduced 62.24%
4,152 $337,000
Q4 2020

Feb 12, 2021

BUY
$80.74 - $97.7 $288,887 - $349,570
3,578 Added 48.24%
10,995 $956,000
Q3 2020

Nov 12, 2020

BUY
$85.07 - $109.69 $108,209 - $139,525
1,272 Added 20.7%
7,417 $665,000
Q2 2020

Aug 12, 2020

SELL
$74.18 - $108.93 $586,689 - $861,527
-7,909 Reduced 56.28%
6,145 $638,000
Q1 2020

May 13, 2020

BUY
$63.18 - $85.97 $342,119 - $465,527
5,415 Added 62.68%
14,054 $1.03 Million
Q4 2019

Feb 13, 2020

BUY
$73.04 - $95.72 $630,992 - $826,925
8,639 New
8,639 $754,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16.9B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Banco Bilbao Vizcaya Argentaria, S.A. Portfolio

Follow Banco Bilbao Vizcaya Argentaria, S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Banco Bilbao Vizcaya Argentaria, S.A., based on Form 13F filings with the SEC.

News

Stay updated on Banco Bilbao Vizcaya Argentaria, S.A. with notifications on news.